Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Cash from Financing Activities (2024 - 2025)

Beta Bionics' Cash from Financing Activities history spans 2 years, with the latest figure at $1.1 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 98.14% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $214.9 million, up 286.36%, while the annual FY2025 figure was $214.9 million, 286.36% up from the prior year.
  • Cash from Financing Activities for Q4 2025 was $1.1 million at Beta Bionics, down from $2.7 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $211.1 million in Q1 2025 and bottomed at -$1.2 million in Q3 2024.